Advanced Lung Squamous Cell Carcinoma
Conditions
Brief summary
This is a descriptive observational study, in which data are collected in an epidemiological fashion and prospective. This study does not intend to intervene the current medical practice of the recruited patients.
Interventions
OTHERNo treatment is included in this study
No drug intervention or tissue sampling will be included in this study.
Sponsors
Hunan Province Tumor Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients must be ≥18 years. * Provision of fully informed consent prior to any study specific procedures. * Advanced or metastatic lung squamous cell carcinoma confirmed by histology or cytology. * According to the RECIST 1.1 standard, the patient must have at least one measurable lesion.
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| progression-free survival | 2 years | From registration onto that step until death, or censored at the date of last contact. |
| Overall survival | 2 years | From registration onto that step until death, or censored at the date of last contact. |
Countries
China
Contacts
Primary ContactYongchang C Zhang, MD
Backup ContactNong Yang, MD
Outcome results
None listed